194 related articles for article (PubMed ID: 9202537)
1. T1a and T1b breast cancer: a twelve-year experience.
Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node dissection in breast cancer: an evolving question?
Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F
Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node status of T1 primary breast cancer in a diverse population.
Madan AK; Macareo L; Winfrey K; Beech DJ
Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
[TBL] [Abstract][Full Text] [Related]
5. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
6. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
Shoup M; Malinzak L; Weisenberger J; Aranha GV
Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
[TBL] [Abstract][Full Text] [Related]
7. T1a breast carcinoma and the role of axillary dissection.
Schneidereit NP; Davis N; Mackinnon M; Speers CH; Truong PT; Olivotto IA
Arch Surg; 2003 Aug; 138(8):832-7. PubMed ID: 12912740
[TBL] [Abstract][Full Text] [Related]
8. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma.
Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J
Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection: does it have a role in primary breast cancer?
Pack MS; Thomas RS
Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
[TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node metastasis in stage T1a breast cancer: a pathologic review of 82 patients.
Whitten TM; Fraser HR; Christensen WN; Turk PS
Am Surg; 1997 Feb; 63(2):144-9. PubMed ID: 9012428
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.
Orr RK; Col NF; Kuntz KM
Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611
[TBL] [Abstract][Full Text] [Related]
14. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
Reddy SG; Kiel KD
Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
[TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
16. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
Vitucci C; Tirelli C; Graziano F; Santoro E
J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
18. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
19. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
